From his journalistic point of view, Jaekwon Son will discuss competitiveness and weaknesses of Samsung and Psy that have recently made top news stories.

Son is a 2012-2013 visiting scholar with the Korean Studies Program at the Shorenstein Asia-Pacific Research Center. Son, a reporter at the Maeil Business Newspaper in Korea, conducts research on the impact of new media journalism, such as social networking through smart devices. He has co-authored several books including The Appstore Economics (2010), Mobile Changes the World (2010), and The Naver Republic (2007). He has been awarded Jounalist of the Month from the Korea Jounalist Association (2012) and Jounalist of the Year from the Hanvit Culture Foundation (2008).

Son holds a BA in classical Chinese from Korea University.

South Korea's Manchurian action films have recently received critical interest for the genre’s unique configuration of such themes as colonial history, nationalism, masculinity, geography and generic hybridity.  This presentation revisits the genre with a different thematic focus and question: the political economy of anti-colonial nationalism.  More specifically, it brings attention to the logic of money inherent in the genre and explores the broad implications of this thematic convention.  Contrary to the genre’s lofty political agenda, Manchurian action films collectively render the unsettling and scandalous trappings of anti-colonial nationalism of South Korea. 

In this session of the Shorenstein APARC Corporate Affiliate Visiting Fellows Research Presentations, the following will be presented:

Niranjan Acharya, "Follow-on Biologics - Oppoertunities and Challenges in the U.S. Market

The pharmaceutical market in the United States is the largest in the world.  Currently, the percentage of GDP spending towards healthcare is the highest and is expected to be on the rise in coming years.  As a result, it is imperative to look for avenues to reduce the burden on the system. 

When compared to the overall pharmaceuticals market, biologics though, garner a minuscule share in prescriptions.  However, this equates into 15% of the market value, which is high compared to the number of prescriptions.  In his presentation, Acharya suggests biologics as one of the options to reduce the cost of healthcare spending and attempts to understand the overall opportunities and challenges for follow-on biologics in  the United States.

Xiaoyuan Shi, "Emerging Trends of Internal Audit in Risk Management"

The business world is becoming increasingly complex due to new, evolving and emerging risks.  Organizations are giving risk management more consideration, internal auditors are finding they can play important roles in risk management and may become a powerful promoter of enterprise risk management practices.  How can internal auditors shape their future?  In her presentation, Shi will introduce current internal audit activities and provide some insight into the direction of how internal auditors expect to perform in the coming years.  Shi will also provide her analysis of what is and what should be the role of internal audit in risk management. 

Guoqiang Zhao, "What Can China Learn from the U.S. Financial Crisis?"

The 2007-09 financial crisis triggered by the burst of the housing bubble proved to be the worst since the Great Depression of the 1930s.  As boom and bust repeated periodically, Zhao has tried to find out the vulnerabilities in both the private and public sector that caused this recent crisis to be so devastating.  Zhao shares recommendations for the reform of the Chinese financial system. 

In this session of the Shorenstein APARC Corporate Affiliate Visiting Fellows Research Presentations, the following will be presented:

Sanat Deshpande, "Best Practices in Pharmaceutical Supply Chain Management"

The pharmaceutical supply chain is very complex and highly responsible to ensure that the right drug reaches the right person at the right time in the right condition to meet the medical needs to fight against disease.  Anything less than 100% service level is unacceptable.  The pharmaceutical industry is facing a series of challenges such as counterfeiting and cold chain management.  In addition to these challenges, developed countries like the United States are also dealing with the patent cliff and healthcare reforms.  There is a growing oversight by the regulatory authorities across the world to ensure patient safety when it comes to pharmaceuticals.  In his presentation, Deshpande will discuss the growth of the pharmaceutical industry focusing on the challenges faced by the supply chain and key areas where companies can improve for the future.

Ryo Masuda, "What Can the Cable TV Industry Learn from the Strengths of Over-The-Top Providers"

One of the biggest concerns for the cable TV (CATV) industry in the United States has been the competition with Over-the-Top providers (OTT).  OTT providers like Netflix and Hulu have been successful in penetrating its service in recent years by providing customers with TV content over the internet for a cheaper monthly flat rate.  Masuda has analyzed the current fundamental differences in service strategies of CATV and OTT providers and their customer behavior. In his research presentation, Masuda tries to answer the question – “Can the CATV industry really compete with OTT providers and what can we learn from those strengths to develop services in the future?” 

Wei Shi, "A Comparison Between the U.S. and China's Credit Card Markets - The Englightenment to the Development of ICBC's Credit Card Business"

Based on a statement of the basic information of China’s credit card market development and a comparison to that of the United States, Shi has researched the main problems that China’s credit card industry currently faces.  He has focused especially on the case for the Industrial and Commercial Bank of China (ICBC) by studying market conditions, credit environment, management risks, and regulatory policy, as well as the reasons and causes of these conditions.  Based on his findings, Shi proposes suggested solutions that will help to further develop the credit card business at ICBC.